What does MED DUPUIS-REYNAERT NEUROPSY do?

MED DUPUIS-REYNAERT NEUROPSY is a specialist medical practice in Grez-Doiceau. Private Limited, started on 22 May 2018, 1 establishment.

What is the address of MED DUPUIS-REYNAERT NEUROPSY?

The registered office of MED DUPUIS-REYNAERT NEUROPSY is located at Avenue des Chardonnerets 2, 1390 Grez-Doiceau.

Is MED DUPUIS-REYNAERT NEUROPSY still active?

Yes. According to the CBE (21 September 2026) MED DUPUIS-REYNAERT NEUROPSY is active, legal situation “Normale toestand”, started on 22 May 2018.

Is MED DUPUIS-REYNAERT NEUROPSY registered on Peppol?

No, MED DUPUIS-REYNAERT NEUROPSY is currently not registered on the Peppol network.

What is the enterprise number of MED DUPUIS-REYNAERT NEUROPSY?

The enterprise number of MED DUPUIS-REYNAERT NEUROPSY is BE0696668945.

When was MED DUPUIS-REYNAERT NEUROPSY founded?

MED DUPUIS-REYNAERT NEUROPSY was founded on 22 May 2018.

Who are the directors of MED DUPUIS-REYNAERT NEUROPSY?

According to the 2025 annual accounts, the directors of MED DUPUIS-REYNAERT NEUROPSY are: Christine REYNAERT, Michel DUPUIS.

Is MED DUPUIS-REYNAERT NEUROPSY a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 May 2018; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did MED DUPUIS-REYNAERT NEUROPSY make in 2025?

MED DUPUIS-REYNAERT NEUROPSY posted a profit after taxes of € 85,407 in financial year 2025.

What is the revenue of MED DUPUIS-REYNAERT NEUROPSY?

As a small company, MED DUPUIS-REYNAERT NEUROPSY is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 197,440.

MED DUPUIS-REYNAERT NEUROPSY (Private Limited)

Dossier MED DUPUIS-REYNAERT NEUROPSY, printed on 21 September 2026 from databakkes.be/en/0696668945/med-dupuis-reynaert-neuropsy. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

MED DUPUIS-REYNAERT NEUROPSY from Grez-Doiceau, company number BE0696668945, closed financial year 2025 with a result of € 85,407 after tax. For that financial year MED DUPUIS-REYNAERT NEUROPSY recorded a gross margin of € 197,440 and equity of € 426,993. Compared with financial year 2024, the result moved from € 48,561 to € 85,407. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Growing

€ 426,993

▲ 25% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 85,407

▲ 76% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 82,425

▼ 45% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 408,393.

People and assets in 2025

Wage cost

€ 51,146

▼ 1% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 65,975

▼ 22% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,598

▼ 15% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 32,545

▲ 98% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 64,976 Gross margin 2022: € 64,976 First fiscal year in the series	€ 116,970 Gross margin 2023: € 116,970 ▲ 80% vs 2022 (€ 64,976) Favourable step	€ 131,362 Gross margin 2024: € 131,362 ▲ 12% vs 2023 (€ 116,970) Favourable step	€ 197,440 Gross margin 2025: € 197,440 ▲ 50% vs 2024 (€ 131,362) Favourable step	▲ 50%
Profit after taxes	€ 11,680 Profit after taxes 2022: € 11,680 First fiscal year in the series	€ 49,655 Profit after taxes 2023: € 49,655 ▲ € 37,975 vs 2022 (€ 11,680) Favourable step	€ 48,561 Profit after taxes 2024: € 48,561 ▼ 2% vs 2023 (€ 49,655) Unfavourable step	€ 85,407 Profit after taxes 2025: € 85,407 ▲ 76% vs 2024 (€ 48,561) Favourable step	▲ 76%
Equity	€ 243,370 Equity 2022: € 243,370 First fiscal year in the series	€ 293,025 Equity 2023: € 293,025 ▲ 20% vs 2022 (€ 243,370) Favourable step	€ 341,586 Equity 2024: € 341,586 ▲ 17% vs 2023 (€ 293,025) Favourable step	€ 426,993 Equity 2025: € 426,993 ▲ 25% vs 2024 (€ 341,586) Favourable step	▲ 25%
Total debts	€ 121,269 Total debts 2022: € 121,269 First fiscal year in the series	€ 76,255 Total debts 2023: € 76,255 ▼ 37% vs 2022 (€ 121,269) Favourable step	€ 79,076 Total debts 2024: € 79,076 ▲ 4% vs 2023 (€ 76,255) Unfavourable step	€ 80,522 Total debts 2025: € 80,522 ▲ 2% vs 2024 (€ 79,076) Unfavourable step	▲ 2%
Cash	€ 191,535 Cash 2022: € 191,535 First fiscal year in the series	€ 195,010 Cash 2023: € 195,010 ▲ 2% vs 2022 (€ 191,535) Favourable step	€ 150,000 Cash 2024: € 150,000 ▼ 23% vs 2023 (€ 195,010) Unfavourable step	€ 82,425 Cash 2025: € 82,425 ▼ 45% vs 2024 (€ 150,000) Unfavourable step	▼ 45%
Retained profit	€ 224,770 Retained profit 2022: € 224,770 First fiscal year in the series	€ 274,425 Retained profit 2023: € 274,425 ▲ 22% vs 2022 (€ 224,770) Favourable step	€ 322,986 Retained profit 2024: € 322,986 ▲ 18% vs 2023 (€ 274,425) Favourable step	€ 408,393 Retained profit 2025: € 408,393 ▲ 26% vs 2024 (€ 322,986) Favourable step	▲ 26%
Balance sheet total	€ 364,639 Balance sheet total 2022: € 364,639 First fiscal year in the series	€ 369,280 Balance sheet total 2023: € 369,280 ▲ 1% vs 2022 (€ 364,639) Unchanged	€ 420,662 Balance sheet total 2024: € 420,662 ▲ 14% vs 2023 (€ 369,280) Unchanged	€ 507,515 Balance sheet total 2025: € 507,515 ▲ 21% vs 2024 (€ 420,662) Unchanged	▲ 21%

Key figures of MED DUPUIS-REYNAERT NEUROPSY, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MED DUPUIS-REYNAERT NEUROPSY?

What happened at MED DUPUIS-REYNAERT NEUROPSY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 30, 2026 New annual accounts for financial year 2025: profit of € 85,407 (▲ 76% vs 2024). Source: NBB ↗
May 23, 2018 New establishment in Grez-Doiceau. KBO
2018 Christine REYNAERT became a director. NBB
2018 Michel DUPUIS became a director. NBB
May 22, 2018 Start of the company according to the CBE. KBO

In short

From € 11,680 profit in 2022 to € 85,407 profit in 2025.

Paid € 84,136 in corporate taxes since 2022.

Best year ever: 2025, with € 85,407 profit.

Original PDFs at the National Bank ↗

A new publication or filing at MED DUPUIS-REYNAERT NEUROPSY? We notify you, reason included.

Follow MED DUPUIS-REYNAERT NEUROPSY

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Christine REYNAERT Michel DUPUIS

MED DUPUIS-REYNAERT NEUROPSY

Behind MED DUPUIS-REYNAERT NEUROPSY are Christine REYNAERT and Michel DUPUIS.

See the full network in the app

Directors

According to the 2025 annual accounts

Christine REYNAERT

Director

since 2018

Michel DUPUIS

Director

since 2018

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue des Chardonnerets 2

1390 Grez-Doiceau

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0696.668.945
VAT number: BE 0696.668.945
Registered office: Avenue des Chardonnerets 2, 1390 Grez-Doiceau
Names & denominations: MED DUPUIS-REYNAERT NEUROPSY
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 22 May 2018
Peppol: Not registered
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗